CAS: 379228-59-8 - 7-Fluoro-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4(3H)-quinazolinone
Formula:C13H13FN2O3
InChI:InChI=1S/C13H13FN2O3/c14-8-5-10-12(13(17)16-7-15-10)11(6-8)19-9-1-3-18-4-2-9/h5-7,9H,1-4H2,(H,15,16,17)
InChI key:InChIKey=NSLYYBACQVUVEJ-UHFFFAOYSA-N
SMILES:O=C1N=CNC=2C=C(F)C=C(OC3CCOCC3)C12
- Synonyms:
- 7-Fluoro-5-tetrahydropyran-4-yloxy-3,4-dihydroquinazolin-4-one
- 4(3H)-Quinazolinone, 7-fluoro-5-[(tetrahydro-2H-pyran-4-yl)oxy]-
- 7-Fluoro-5-(oxan-4-yloxy)-3,4-dihydroquinazolin-4-one
- 4(1H)-Quinazolinone, 7-fluoro-5-[(tetrahydro-2H-pyran-4-yl)oxy]-
- 7-Fluoro-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4(3H)-quinazolinone
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
4(3H)-Quinazolinone, 7-fluoro-5-[(tetrahydro-2H-pyran-4-yl)oxy]- REF: IN-DA00D5O3CAS: 379228-59-8 | - - - | To inquire | Tue 10 Dec 24 | |
7-Fluoro-5-((tetrahydro-2H-pyran-4-yl)oxy)quinazolin-4(3H)-one REF: 3D-EQA22859CAS: 379228-59-8 | Min. 95% | To inquire | Tue 21 Jan 25 | |
7-fluoro-5-(oxan-4-yloxy)-1,4-dihydroquinazolin-4-one REF: 10-F773452CAS: 379228-59-8 | 98% | - - - | Discontinued product |
4(3H)-Quinazolinone, 7-fluoro-5-[(tetrahydro-2H-pyran-4-yl)oxy]-
CAS:379228-59-8
Formula:
C13H13FN2O3
Molecular weight:
264.2523
Ref: IN-DA00D5O3
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
7-Fluoro-5-((tetrahydro-2H-pyran-4-yl)oxy)quinazolin-4(3H)-one
CAS:379228-59-8
Please enquire for more information about 7-Fluoro-5-((tetrahydro-2H-pyran-4-yl)oxy)quinazolin-4(3H)-one including the price, delivery time and more detailed …
Formula:
C13H13FN2O3
Purity:
Min. 95%
Molecular weight:
264.25 g/mol
Ref: 3D-EQA22859
1g | To inquire | ||
5g | To inquire | ||
100mg | To inquire | ||
250mg | To inquire | ||
500mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
7-fluoro-5-(oxan-4-yloxy)-1,4-dihydroquinazolin-4-one
CAS:379228-59-8
Purity:
98%
Molecular weight:
264.2560119628906
Ref: 10-F773452
1g | Discontinued | Request information | |
500mg | Discontinued | Request information |